Latest filing published 23 May 2019 for 4D Pharma plc, €12k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Duncan Peyton: trading record in brief
All filings by Duncan Peyton on record concern 4D Pharma plc. Between 14 March 2019 and 23 May 2019, the trades on record add up to 3 filings.
The open-market record is one-sided, with 3 purchases worth €215k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The median purchase comes to €34k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The newest entry dates from 23 May 2019: an open-market purchase of €12k, in 4D Pharma plc. Half of the filings or more reach the RNS (LSE) feed on the day of the trade. The legal deadline for notifying a trade is three business days (UK MAR). These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Duncan Peyton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,891 shares@ £1.056.5% of flowLondon Stock Exchange, AIMISIN GB00BJL5BR07FCA-NSM:LSE20190523070009_14084402_20200326185141958_9509Canonical exit: 21 Aug 2019 (T+90)
- 152,197 shares@ £0.9893.5% of flowLondon Stock Exchange, AIMISIN GB00BJL5BR07FCA-NSM:LSE20190522070006_14082715_20200326185142053_11038-1Canonical exit: 20 Aug 2019 (T+90)
- 31,666 shares@ £0.91515.8% of flowLondon Stock Exchange, AIMISIN GB00BJL5BR07FCA-NSM:LSE20190314070020_14001563_20200326185133974_17152Canonical exit: 12 Jun 2019 (T+90)
3 of 3 declarations